| scholarly article | Q13442814 |
| P50 | author | José Manuel Rodríguez Martínez | Q54449621 |
| Fernando Docobo-Pérez | Q57016958 | ||
| Jerónimo Rodríguez-Beltrán | Q59677616 | ||
| Alvaro Pascual | Q60594097 | ||
| Guillermo Martín-Gutiérrez | Q61122722 | ||
| Jesus Blazquez | Q68273789 | ||
| P2093 | author name string | J Aznar | |
| J Rodriguez-Beltrán | |||
| P2860 | cites work | Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance | Q26853135 |
| Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure | Q34019104 | ||
| The mechanism of action of fosfomycin (phosphonomycin) | Q34214482 | ||
| Low-level antibacterial resistance: a gateway to clinical resistance | Q34341270 | ||
| Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections | Q34421301 | ||
| The epidemiology of urinary tract infection | Q34625661 | ||
| Epidemiology of urinary tract infections: incidence, morbidity, and economic costs | Q34735081 | ||
| Novel inhibitors of bacterial cell wall synthesis. | Q35565580 | ||
| Biological costs and mechanisms of fosfomycin resistance in Escherichia coli | Q35685710 | ||
| Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost | Q35941216 | ||
| Transport of antibiotics and metabolite analogs by systems under cyclic AMP control: positive selection of Salmonella typhimurium cya and crp mutants | Q36417093 | ||
| Fosfomycin | Q36675246 | ||
| Isolation and Characterization of a Phosphonomycin-Resistant Mutant of Escherichia coli K-12 | Q36776831 | ||
| Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli. | Q37023257 | ||
| Antibiotic resistance and its cost: is it possible to reverse resistance? | Q37704177 | ||
| Treatment and prevention of kidney stones: an update. | Q37965840 | ||
| Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria | Q38160759 | ||
| Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study. | Q39119548 | ||
| Two kinds of mutants defective in multiple carbohydrate utilization isolated from in vitro fosfomycin-resistant strains of Escherichia coli K-12 | Q40145885 | ||
| Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities | Q40175191 | ||
| Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates | Q40333130 | ||
| Plasmidic qnr Genes Confer Clinical Resistance to Ciprofloxacin under Urinary Tract Physiological Conditions. | Q40368674 | ||
| Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae. | Q40381942 | ||
| Human bladder urine oxygen content: implications for urinary tract diseases | Q40657667 | ||
| Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis | Q40681302 | ||
| Conditional lethal amber mutations in essential Escherichia coli genes | Q40763518 | ||
| Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions | Q41066081 | ||
| Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs | Q41169926 | ||
| Extracellular concentrations of fosfomycin in lung tissue of septic patients | Q43130327 | ||
| Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli | Q43195414 | ||
| Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation | Q43289024 | ||
| Some unusual features of gouty arthritis in females | Q43655598 | ||
| Intravenous Fosfomycin Treatment for Carbapenem-Resistant Klebsiella pneumoniae in the United States | Q44009246 | ||
| In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance | Q44607486 | ||
| Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. | Q44824183 | ||
| High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection. | Q45939590 | ||
| Molecular insights into fosfomycin resistance in Escherichia coli. | Q50950504 | ||
| A theoretical and experimental analysis of bacterial growth in the bladder | Q52426375 | ||
| [Perioperative preventive antibiotic treatment with fosfomycin in heart surgery: serum kinetics in extracorporeal circulation and determination of concentration in heart valve tissue] | Q54091339 | ||
| Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine. | Q54326424 | ||
| Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. | Q54349458 | ||
| Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo- -lactamase-producing Klebsiella oxytoca | Q59617326 | ||
| Trometamol-fosfomycin (Monuril) bioavailability and food-drug interaction | Q68988798 | ||
| Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces | Q72475705 | ||
| Impact of pH on bacterial growth and activity of recent fluoroquinolones in pooled urine | Q83354580 | ||
| Gitelman syndrome with hiponatremia, a rare presentation | Q87496045 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P577 | publication date | 2017-12-21 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake | |
| P478 | volume | 62 |
Search more.